Large T antigen-specific cytotoxicT cells protect against dendritic cell tumors tnrougn perforin-mediated mechanisms independent of CD4T cell help

被引:5
作者
Duval, Anais [1 ]
Marraco, Silvia A. Fuertes [1 ]
Schwitter, Dominik [1 ]
Leuenberger, Line [1 ]
Acha-Orbea, Hans [1 ]
机构
[1] Univ Lausanne, Ctr Immun & Infect Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland
基金
瑞士国家科学基金会;
关键词
largeT antigen; dendritic cell; CD8T cell; CD4T cells; perforin; tolerance; RESPONSES;
D O I
10.3389/fimmu.2014.00338
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Our newly generated murine tumor dendritic cell (MuTuDC) lines, generated from tumors developing in transgenic mice expressing the simian virus 40 large T antigen (SV40LgT) and GFP under the DC specific promoter CD11c, reproduce the phenotypic and functional properties of splenic wild type CD8 alpha(+) conventional DCs. They have an immature phenotype with low co-stimulation molecule expression (CD40, CD70, CD80, and CD86) that is upregulated after activation with toll-like receptor ligands. We observed that after transfer into syngeneic C57BL/6 mice, MuTuDC lines were quickly rejected. Tumors grew efficiently in large T transgene-tolerant mice. To investigate the immune response toward the large T antigen that leads to rejection of the MuTuDC lines, they were genetically engineered by lentiviral transduction to express luciferase and tested for the induction of DC tumors after adoptive transfer in various gene deficient recipient mice. Here, we document that the MuTuDC line was rejected in C57BL/6 mice by a CD4T cell help-independent, perforin-mediated CD8 T cell response to the SV40LgT without pre-activation or co-injection of adjuvants. Using depleting anti-CD8 beta antibodies, we were able to induce efficient tumor growth in C57BL/6 mice. These results are important for researchers who want to use the MuTuDC lines for in vivo studies.
引用
收藏
页数:8
相关论文
共 22 条
[1]   Regulation of antigen-specific CD8+ T cell homeostasis by perforin and interferon-γ [J].
Badovinac, VP ;
Tvinnereim, AR ;
Harty, JT .
SCIENCE, 2000, 290 (5495) :1354-1357
[2]   Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance [J].
Bonifaz, L ;
Bonnyay, D ;
Mahnke, K ;
Rivera, M ;
Nussenzweig, MC ;
Steinman, RM .
JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 196 (12) :1627-1638
[3]   In vivo depletion of CD11c+ dendritic cells abrogates priming of CD8+ T cells by exogenous cell-associated antigens [J].
Jung, S ;
Unutmaz, D ;
Wong, P ;
Sano, GI ;
De los Santos, K ;
Sparwasser, T ;
Wu, SJ ;
Vuthoori, S ;
Ko, K ;
Zavala, F ;
Pamer, EG ;
Littman, DR ;
Lang, RA .
IMMUNITY, 2002, 17 (02) :211-220
[4]   Novel murine dendritic cell lines: a powerful auxiliary tool for dendritic cell research [J].
Marraco, Silvia A. Fuertes ;
Grosjean, Frederic ;
Duval, Anais ;
Rosa, Muriel ;
Lavanchy, Christine ;
Ashok, Devika ;
Haller, Sergio ;
Otten, Luc A. ;
Steiner, Quynh-Giao ;
Descombes, Patrick ;
Luber, Christian A. ;
Meissner, Felix ;
Mann, Matthias ;
Szeles, Lajos ;
Reith, Walter ;
Acha-Orbea, Hans .
FRONTIERS IN IMMUNOLOGY, 2012, 3
[5]   Tumor-specific CD4+ T cells have a major "post-licensing" role in CTL mediated anti-tumor immunity [J].
Marzo, AL ;
Kinnear, BF ;
Lake, RA ;
Frelinger, JJ ;
Collins, EJ ;
Robinson, BWS ;
Scott, B .
JOURNAL OF IMMUNOLOGY, 2000, 165 (11) :6047-6055
[6]   A role for perforin in downregulating T-cell responses during chronic viral infection [J].
Matloubian, M ;
Suresh, M ;
Glass, A ;
Galvan, M ;
Chow, K ;
Whitmire, JK ;
Walsh, CM ;
Clark, WR ;
Ahmed, R .
JOURNAL OF VIROLOGY, 1999, 73 (03) :2527-2536
[7]   Quantitation of CD8+ T-lymphocyte responses to multiple epitopes from simian virus 40 (SV40) large T antigen in C57BL/6 mice immunized with SV40, SV40 T-antigen-transformed cells, or vaccinia virus recombinants expressing full-length T antigen or epitope minigenes [J].
Mylin, LM ;
Schell, TD ;
Roberts, D ;
Epler, M ;
Boesteanu, A ;
Collins, EJ ;
Frelinger, JA ;
Joyce, S ;
Tevethia, SS .
JOURNAL OF VIROLOGY, 2000, 74 (15) :6922-6934
[8]   Exploiting the Role of Endogenous Lymphoid-Resident Dendritic Cells in the Priming of NKT Cells and CD8+T Cells to Dendritic Cell-Based Vaccines [J].
Petersen, Troels R. ;
Sika-Paotonu, Dianne ;
Knight, Deborah A. ;
Simkins, Helen M. A. ;
Hermans, Ian F. .
PLOS ONE, 2011, 6 (03)
[9]   Resting dendritic cells induce peripheral CD8+ T cell tolerance through PD-1 and CTLA-4 [J].
Probst, HC ;
McCoy, K ;
Okazaki, T ;
Honjo, T ;
van den Broek, M .
NATURE IMMUNOLOGY, 2005, 6 (03) :280-286
[10]  
REID GH, 1979, CANCER RES, V39, P4724